Stay updated on LY3454738 Clinical Trial in Atopic Dermatitis
Sign up to get notified when there's something new on the LY3454738 Clinical Trial in Atopic Dermatitis page.

Latest updates to the LY3454738 Clinical Trial in Atopic Dermatitis page
- Check3 days agoChange DetectedA site-wide banner announces NIH website transition updates and says some content may use “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI).SummaryDifference1%

- Check10 days agoChange DetectedThe footer revision identifier changed from v3.7.1 to v3.7.2, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check17 days agoChange DetectedThe footer revision identifier changes from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check38 days agoChange DetectedThe study page now displays a 403 Forbidden error page, replacing the study details with a generic site header/footer and a Home button.SummaryDifference18%

- Check59 days agoChange DetectedThe page revision label was updated from v3.6.5 to v3.6.6, indicating a new release of the page. The study content and details shown to users remain unchanged.SummaryDifference0.1%

- Check73 days agoChange DetectedThis update replaces an error page with the actual study record content for LY3454738 in healthy participants and participants with atopic dermatitis, including title, sponsor, design, and locations. It provides key trial details such as enrollment, primary and secondary outcomes, and participating sites, which are core pieces of information users expect on a study page.SummaryDifference58%

Stay in the know with updates to LY3454738 Clinical Trial in Atopic Dermatitis
Enter your email address, and we'll notify you when there's something new on the LY3454738 Clinical Trial in Atopic Dermatitis page.